Report Detail
Global (United States, European Union and China) Non-Invasive Cancer Diagnostics Market Research Report 2019-2025
- RnM3659566 |
- 09 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
In 2019, the market size of Non-Invasive Cancer Diagnostics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Non-Invasive Cancer Diagnostics.
This report studies the global market size of Non-Invasive Cancer Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Non-Invasive Cancer Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Market Segment by Product Type
CTCs
CTNAS
Exosomes
Market Segment by Application
Blood
Urine
Saliva
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Non-Invasive Cancer Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Non-Invasive Cancer Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Non-Invasive Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 CTCs
- 1.3.3 CTNAS
- 1.3.4 Exosomes
- 1.4 Market Segment by Application
- 1.4.1 Global Non-Invasive Cancer Diagnostics Market Share by Application (2019-2025)
- 1.4.2 Blood
- 1.4.3 Urine
- 1.4.4 Saliva
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Non-Invasive Cancer Diagnostics Market Size
- 2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2014-2025
- 2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2014-2025
- 2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
- 2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions 2014-2019
- 2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
- 3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers 2014-2019
- 3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
- 3.4 Key Manufacturers Non-Invasive Cancer Diagnostics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
- 3.6 Key Manufacturers Non-Invasive Cancer Diagnostics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 CTCs Sales and Revenue (2014-2019)
- 4.1.2 CTNAS Sales and Revenue (2014-2019)
- 4.1.3 Exosomes Sales and Revenue (2014-2019)
- 4.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type
- 4.3 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type
- 4.4 Non-Invasive Cancer Diagnostics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Non-Invasive Cancer Diagnostics Sales by Application
6 United States
- 6.1 United States Non-Invasive Cancer Diagnostics Breakdown Data by Company
- 6.2 United States Non-Invasive Cancer Diagnostics Breakdown Data by Type
- 6.3 United States Non-Invasive Cancer Diagnostics Breakdown Data by Application
7 European Union
- 7.1 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Company
- 7.2 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Type
- 7.3 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Application
8 China
- 8.1 China Non-Invasive Cancer Diagnostics Breakdown Data by Company
- 8.2 China Non-Invasive Cancer Diagnostics Breakdown Data by Type
- 8.3 China Non-Invasive Cancer Diagnostics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Company
- 9.2 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Type
- 9.3 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Application
- 9.4 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Countries
- 9.4.1 Rest of World Non-Invasive Cancer Diagnostics Sales by Countries
- 9.4.2 Rest of World Non-Invasive Cancer Diagnostics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Gen-Probe Inc
- 10.1.1 Gen-Probe Inc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.1.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.1.5 Gen-Probe Inc Recent Development
- 10.2 Digene Corporation
- 10.2.1 Digene Corporation Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.2.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.2.5 Digene Corporation Recent Development
- 10.3 Quest Diagnostics Inc
- 10.3.1 Quest Diagnostics Inc Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.3.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.3.5 Quest Diagnostics Inc Recent Development
- 10.4 Cancer, Genetics Inc
- 10.4.1 Cancer, Genetics Inc Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.4.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.4.5 Cancer, Genetics Inc Recent Development
- 10.5 BIOVIEW Inc
- 10.5.1 BIOVIEW Inc Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.5.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.5.5 BIOVIEW Inc Recent Development
- 10.6 AVIVA Biosciences Corporation
- 10.6.1 AVIVA Biosciences Corporation Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.6.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.6.5 AVIVA Biosciences Corporation Recent Development
- 10.7 Laboratory Corporation of America Holdings (LabCorp)
- 10.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.7.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
- 10.8 A&G Pharmaceutical
- 10.8.1 A&G Pharmaceutical Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.8.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.8.5 A&G Pharmaceutical Recent Development
- 10.9 Affymetrix Inc
- 10.9.1 Affymetrix Inc Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.9.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.9.5 Affymetrix Inc Recent Development
- 10.10 Precision Therapeutics
- 10.10.1 Precision Therapeutics Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
- 10.10.4 Non-Invasive Cancer Diagnostics Product Introduction
- 10.10.5 Precision Therapeutics Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Non-Invasive Cancer Diagnostics Sales Channels
- 11.2.2 Non-Invasive Cancer Diagnostics Distributors
- 11.3 Non-Invasive Cancer Diagnostics Customers
12 Market Forecast
- 12.1 Global Non-Invasive Cancer Diagnostics Sales and Revenue Forecast 2019-2025
- 12.2 Global Non-Invasive Cancer Diagnostics Sales Forecast by Type
- 12.3 Global Non-Invasive Cancer Diagnostics Sales Forecast by Application
- 12.4 Non-Invasive Cancer Diagnostics Forecast by Regions
- 12.4.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Non-Invasive Cancer Diagnostics . Industry analysis & Market Report on Non-Invasive Cancer Diagnostics is a syndicated market report, published as Global (United States, European Union and China) Non-Invasive Cancer Diagnostics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Non-Invasive Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
